Sharpens Resmed’s focus on high-growth sleep and connected care marketsSAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep ...

July 7 (Reuters) - ResMed said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier Healthcare Partners for $490 million in cash, as the health technology company ...

Resmed said it would sell its MatrixCare business to Frazier Healthcare Partners, a health-care focused private equity firm, for $490 million. Resmed, a global medical equipment company, said it ...

ResMed is selling its MatrixCare home-health software unit to Frazier Healthcare Partners for $490m in cash to focus on sleep and breathing care.

The medical device maker has sold the MatrixCare business for less than it bought it eight years ago, with analysts pointing ...

Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has entered ...

Frazier Healthcare to acquire MatrixCare from Resmed (RMD), a cloud EHR leader in post-acute care, with close expected in Q3 2026—read the deal details.

ResMed Inc. (ASX:RMD) has moved to simplify its business and sharpen its focus on sleep, breathing and connected home ...

The sleep health device manufacturer is selling its MatrixCare business to a US-based private equity firm for $707 million - ...

Find insight on Eli Lilly, ResMed, Vertex Pharmaceuticalsand more in the latest Market Talks covering health care.

Resmed (RMD) said on Tuesday it agreed to sell its MatrixCare business to private equity firm Frazier Healthcare Partners as the medical device maker sharpens its focus on sleep, breathing and ...

Australian shares declined on Wednesday as investors reacted to a surge in oil prices on the back of renewed hostilities ...